Home›Companies›Healthcare›Nuvaira

Nuvaira, Inc.

Develops a lung treatment device for people with chronic obstructive pulmonary disease.

Updated Nov 11, 2026·Latest SEC filing Mar 4, 2026·Suggest an edit

About Nuvaira

Nuvaira is a private company based in Minneapolis, Minnesota. It has reported $177,942,639 raised in 12 offerings on Form D since April 2009. Its chief executive is Dennis Wahr.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 20, 2026Mar 4, 2026$35,764,878of $63.5M target9$3.9MEquity, Conversion of SAFEs; Conversion of debtRule 506(b)Form D ↗
Aug 11, 2025Aug 25, 2025$979,184of $2.5M target8$122KOptionsRule 506(b)Form D ↗
Apr 24, 2024May 9, 2024$52,875of $56,382 target13$4,067EquityRule 504Form D ↗
Nov 28, 2023Dec 1, 2023$15,124,893of $17.2M target39$387KEquityRule 506(b)Form D ↗
Jul 13, 2020Jul 29, 2020amended Jan 19, 2022$31,337,640of $68.2M target49$639KEquityRule 506(b)Form D/A ↗2 earlier filings
Feb 7, 2019Feb 14, 2019$25,000,004of $75.0M target20$1.2MEquityRule 506(b)Form D ↗
Apr 6, 2018May 15, 2018$4,000,011of $8.0M target9$444KDebt, OptionsRule 506(b)Form D ↗
Apr 2, 2014Apr 7, 2014$42,000,011fully sold9$4.6MEquityRule 506(b)Form D ↗
Feb 8, 2013Feb 21, 2013$10,000,000fully sold5$2.0MEquity06Form D ↗
Mar 23, 2012Apr 6, 2012$10,600,007fully sold16$662KEquity06Form D ↗
Sep 15, 2010Sep 29, 2010$3,000,000of $8.0M target3$1.0MEquity06Form D ↗
Mar 31, 2009Apr 14, 2009$83,136of $500K target3$27,712Debt, Options, Securities on exercise06Form D ↗
Total, 12 offerings$177,942,639

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nuvaira's Form D filed Mar 4, 2026.

EM
GD
TH
Dennis Wahr
Dennis Wahr
President & CEO, director

Earlier filings also listed Doug Sisson (director, last listed Aug 2025), Tom Griffin (executive officer, last listed May 2024), Mike Carusi (director, last listed May 2024), Jonathan Root (director, last listed May 2024), Jaques Essinger (director, last listed May 2024), Henry Plain, Jr. (director, last listed May 2024), David Van Meter (director, last listed May 2024) and Jacques Essinger (director, last listed Dec 2023).

Sources

  1. SECNUVAIRA, INC. Form D/A, filed Jan 15, 2021
  2. SECNUVAIRA, INC. Form D, filed Jul 29, 2020
  3. SECNUVAIRA, INC. filing history
  4. CompanyAbout Nuvaira